{"data":[{"accessionNo":"0001315082-26-000002","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","personName":"RA Capital Healthcare Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common Stock","broker":"Goldman Sachs & Co","unitsToSell":3448811,"aggregateMarketValue":21834318,"unitsOutstanding":45212399,"approxSaleDate":"2026-09-17","exchange":"Nasdaq GM","filedAt":"2026-09-17","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001950047-26-006887","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","personName":"JENNIFER FITZPATRICK","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10250,"aggregateMarketValue":450897.5,"unitsOutstanding":45150330,"approxSaleDate":"2026-07-06","exchange":"NASDAQ","filedAt":"2026-07-06","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000947871-26-000589","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"OrbiMed Private Investments VIII, LP","relationship":"Shareholder","securityClass":"Common Stock","broker":"TD Cowen","unitsToSell":210876,"aggregateMarketValue":9029710.32,"unitsOutstanding":45150330,"approxSaleDate":"2026-05-29","exchange":"Nasdaq Stock Market","filedAt":"2026-06-01","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000947871-26-000586","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"OrbiMed Private Investments VIII, LP","relationship":"Shareholder","securityClass":"Common Stock","broker":"TD Cowen","unitsToSell":1082480,"aggregateMarketValue":46330144,"unitsOutstanding":45150330,"approxSaleDate":"2026-05-29","exchange":"Nasdaq Stock Market","filedAt":"2026-05-29","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001950047-26-002261","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS INC","ticker":"SION","personName":"JENNIFER FITZPATRICK","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10250,"aggregateMarketValue":354342.5,"unitsOutstanding":44998073,"approxSaleDate":"2026-03-05","exchange":"NASDAQ","filedAt":"2026-03-05","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001999371-26-001475","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Rise Fund Sling, L.P.","relationship":"Stockholder","securityClass":"Common Stock, $0.001 par value per share","broker":"Goldman Sachs & Co. LLC","unitsToSell":195667,"aggregateMarketValue":8173010.59,"unitsOutstanding":44628788,"approxSaleDate":"2026-01-22","exchange":"Nasdaq Global Market","filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001999371-26-001474","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Rise Fund Sling II, L.P.","relationship":"Stockholder","securityClass":"Common Stock, $0.001 par value per share","broker":"Goldman Sachs & Co. LLC","unitsToSell":54333,"aggregateMarketValue":2269489.41,"unitsOutstanding":44628788,"approxSaleDate":"2026-01-22","exchange":"Nasdaq Global Market","filedAt":"2026-01-22","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001950047-25-009861","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS INC","ticker":"SION","personName":"JENNIFER R FITZPATRICK","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10250,"aggregateMarketValue":419020,"unitsOutstanding":44628788,"approxSaleDate":"2025-12-05","exchange":"NASDAQ","filedAt":"2025-12-05","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000947871-25-001041","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"OrbiMed Private Investments VIII, LP","relationship":"Shareholder","securityClass":"Common Stock","broker":"TD Cowen","unitsToSell":1047770,"aggregateMarketValue":46500032.6,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-24","exchange":"Nasdaq Stock Market","filedAt":"2025-11-24","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000082","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":9924,"aggregateMarketValue":433281.84,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-21","exchange":"NASDAQ GM","filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000083","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund III, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":6440,"aggregateMarketValue":281170.4,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-21","exchange":"NASDAQ GM","filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000084","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Healthcare Fund LP","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":1210,"aggregateMarketValue":52828.6,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-21","exchange":"NASDAQ GM","filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000081","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"BLACKWELL PARTNERS LLC - SERIES A","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":7609,"aggregateMarketValue":332208.94,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-21","exchange":"NASDAQ GM","filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000079","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":2023,"aggregateMarketValue":78775.62,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-20","exchange":"NASDAQ GM","filedAt":"2025-11-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000080","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund III, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":1313,"aggregateMarketValue":51128.22,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-20","exchange":"NASDAQ GM","filedAt":"2025-11-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000078","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Healthcare Fund LP","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":246,"aggregateMarketValue":9579.24,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-20","exchange":"NASDAQ GM","filedAt":"2025-11-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000077","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"BLACKWELL PARTNERS LLC - SERIES A","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":1551,"aggregateMarketValue":60395.94,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-20","exchange":"NASDAQ GM","filedAt":"2025-11-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000072","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":18696,"aggregateMarketValue":718113,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-19","exchange":"NASDAQ GM","filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000071","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund III, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":12134,"aggregateMarketValue":466066,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-19","exchange":"NASDAQ GM","filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000075","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Healthcare Fund LP","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":2278,"aggregateMarketValue":89115,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-19","exchange":"NASDAQ GM","filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000074","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"BLACKWELL PARTNERS LLC - SERIES A","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":14334,"aggregateMarketValue":550568,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-19","exchange":"NASDAQ GM","filedAt":"2025-11-19","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000068","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":2728,"aggregateMarketValue":106501.12,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-18","exchange":"NASDAQ GM","filedAt":"2025-11-18","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000067","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund III, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":1770,"aggregateMarketValue":69100,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-18","exchange":"NASDAQ GM","filedAt":"2025-11-18","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000066","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Healthcare Fund LP","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":332,"aggregateMarketValue":12961,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-18","exchange":"NASDAQ GM","filedAt":"2025-11-18","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000069","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"BLACKWELL PARTNERS LLC - SERIES A","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":2092,"aggregateMarketValue":81671,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-18","exchange":"NASDAQ GM","filedAt":"2025-11-18","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000063","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":32310,"aggregateMarketValue":1290138,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-17","exchange":"NASDAQ GM","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000062","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund III, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":20969,"aggregateMarketValue":837292,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-17","exchange":"NASDAQ GM","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000061","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Healthcare Fund LP","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":3936,"aggregateMarketValue":157164,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-17","exchange":"NASDAQ GM","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000064","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"BLACKWELL PARTNERS LLC - SERIES A","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":24772,"aggregateMarketValue":989146,"unitsOutstanding":44628788,"approxSaleDate":"2025-11-17","exchange":"NASDAQ GM","filedAt":"2025-11-17","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000056","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":31392,"aggregateMarketValue":1238414.4,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-28","exchange":"NASDAQ GM","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000058","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund III, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":17118,"aggregateMarketValue":675305.1,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-28","exchange":"NASDAQ GM","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000057","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Healthcare Fund LP","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":3624,"aggregateMarketValue":142966.8,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-28","exchange":"NASDAQ GM","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000055","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"BLACKWELL PARTNERS LLC - SERIES A","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":10476,"aggregateMarketValue":413278.2,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-28","exchange":"NASDAQ GM","filedAt":"2025-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000054","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":122271,"aggregateMarketValue":4794245.91,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-24","exchange":"NASDAQ GM","filedAt":"2025-10-24","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000053","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Nexus Fund III, L.P.","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":66672,"aggregateMarketValue":2614209.12,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-24","exchange":"NASDAQ GM","filedAt":"2025-10-24","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000052","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"RA Capital Healthcare Fund LP","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":14116,"aggregateMarketValue":553488.36,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-24","exchange":"NASDAQ GM","filedAt":"2025-10-24","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001178937-25-000051","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"BLACKWELL PARTNERS LLC - SERIES A","relationship":"Director, 10% Stockholder","securityClass":"Common","broker":"BTIG, LLC","unitsToSell":107941,"aggregateMarketValue":4232366.61,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-24","exchange":"NASDAQ GM","filedAt":"2025-10-24","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001950047-25-008093","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS INC","ticker":"SION","personName":"MICHAEL CLOONAN","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":99800,"aggregateMarketValue":3213560,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-21","exchange":"NASDAQ","filedAt":"2025-10-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045708","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":15418,"aggregateMarketValue":496459.6,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-21","exchange":"NASDAQ","filedAt":"2025-10-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045704","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":73460,"aggregateMarketValue":2365412,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-21","exchange":"NASDAQ","filedAt":"2025-10-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045535","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":9712,"aggregateMarketValue":310104.16,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-20","exchange":"NASDAQ","filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045536","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":46273,"aggregateMarketValue":1477496.89,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-20","exchange":"NASDAQ","filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045360","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":10604,"aggregateMarketValue":346856.84,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-17","exchange":"NASDAQ","filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045359","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":50520,"aggregateMarketValue":1653014.4,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-17","exchange":"NASDAQ","filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001950047-25-008035","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","personName":"MICHAEL CLOONAN","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":200,"aggregateMarketValue":6182,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-16","exchange":"NASDAQ","filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045237","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":29363,"aggregateMarketValue":907610.33,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-16","exchange":"NASDAQ","filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-045238","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":139897,"aggregateMarketValue":4324216.27,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-16","exchange":"NASDAQ","filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001950047-25-008008","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","personName":"MICHAEL CLOONAN","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25000,"aggregateMarketValue":748500,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-15","exchange":"NASDAQ","filedAt":"2025-10-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044973","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":10102,"aggregateMarketValue":297200.84,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-13","exchange":"NASDAQ","filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044974","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":48130,"aggregateMarketValue":1415984.6,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-13","exchange":"NASDAQ","filedAt":"2025-10-14","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044801","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":3511,"aggregateMarketValue":99536.85,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-10","exchange":"NASDAQ","filedAt":"2025-10-10","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044800","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":16727,"aggregateMarketValue":474210.45,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-10","exchange":"NASDAQ","filedAt":"2025-10-10","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044335","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":2047,"aggregateMarketValue":61430.47,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-06","exchange":"NASDAQ","filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044334","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":9753,"aggregateMarketValue":292687.53,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-06","exchange":"NASDAQ","filedAt":"2025-10-06","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044112","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":6548,"aggregateMarketValue":191856.4,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-03","exchange":"NASDAQ","filedAt":"2025-10-03","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-044110","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":31198,"aggregateMarketValue":914101.4,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-03","exchange":"NASDAQ","filedAt":"2025-10-03","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-043421","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":35,"aggregateMarketValue":1029.35,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-01","exchange":"NASDAQ","filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-043423","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":165,"aggregateMarketValue":4852.65,"unitsOutstanding":44139823,"approxSaleDate":"2025-10-01","exchange":"NASDAQ","filedAt":"2025-10-01","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-043234","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":2149,"aggregateMarketValue":63438.48,"unitsOutstanding":44139823,"approxSaleDate":"2025-09-30","exchange":"NASDAQ","filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-043235","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":10239,"aggregateMarketValue":302255.28,"unitsOutstanding":44139823,"approxSaleDate":"2025-09-30","exchange":"NASDAQ","filedAt":"2025-09-30","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-043111","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Opportunity Fund II,  L.P.","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":11468,"aggregateMarketValue":331883.92,"unitsOutstanding":44139823,"approxSaleDate":"2025-09-29","exchange":"NASDAQ","filedAt":"2025-09-29","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001628280-25-043112","issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","personName":"Atlas Venture Fund XI, LP","relationship":"Shareholder","securityClass":"Common","broker":"Merrill Lynch","unitsToSell":54637,"aggregateMarketValue":1581194.78,"unitsOutstanding":44139823,"approxSaleDate":"2025-09-29","exchange":"NASDAQ","filedAt":"2025-09-29","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001950047-25-007533","issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS INC","ticker":"SION","personName":"MICHAEL CLOONAN","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25000,"aggregateMarketValue":687500,"unitsOutstanding":44139823,"approxSaleDate":"2025-09-26","exchange":"NASDAQ","filedAt":"2025-09-26","canonicalUrl":"https://xoomar.com/markets/stocks/sion"}],"updatedAt":"2026-11-05T15:43:18.462Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/sion","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}